Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06142019 · ClinicalTrials.gov registry record

Pulse Oximeter Accuracy in Healthy Humans During Hypoxia

A clinical trial of Hypoxia and Skin Pigmentation, sponsored by University of California, San Francisco.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT06142019 is a study of Hypoxia and Skin Pigmentation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 10,000 participants, above the 2,860-participant average among 39 other Hypoxia trials with a reported enrollment target (250% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06142019, a study of Hypoxia and Skin Pigmentation, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The aim of this project is to test the accuracy of pulse oximeters during mild, moderate and severe hypoxia. This is done by comparing the reading of the pulse oximeter during brief, steady state hypoxia with a gold-standard measurement of blood oxygen. This study will be done on healthy male or females between the age group of 18-50.

Interventions

  • DEVICE Controlled desaturation (hypoxemia)

Study Locations (1)

California

  • Hypoxia Lab, UCSF Department of Anesthesia and Perioperative Care - San Francisco

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2021-11-29
Est. Completion 2028-09-01

What the Registry Record Tells You About NCT06142019

The ClinicalTrials.gov registry entry for NCT06142019 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,860-participant average among 39 other Hypoxia trials with a reported enrollment target (250% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Controlled desaturation (hypoxemia) is the first listed.

NCT06142019 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06142019 about?

NCT06142019 is a clinical study titled "Pulse Oximeter Accuracy in Healthy Humans During Hypoxia". The aim of this project is to test the accuracy of pulse oximeters during mild, moderate and severe hypoxia. This is done by comparing the reading of the pulse oximeter during brief, steady state hypoxia with a gold-standard measurement of blood oxygen. This study will be done on healthy male or fem...

What is the current status of trial NCT06142019?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2021-11-29. Estimated completion is 2028-09-01.

What conditions does trial NCT06142019 study?

This clinical trial studies the following conditions: Hypoxia, Skin Pigmentation.

What interventions are being tested in trial NCT06142019?

The interventions under investigation include: Controlled desaturation (hypoxemia) (DEVICE).

Who is sponsoring clinical trial NCT06142019?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06142019 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.